Epigenetically Guided Cancer Therapy: Targeting H3K27me3 Loss in Pediatric Brain Tumors
Impact Journals - Blog,
“[…] our discovery of H3K27me3 as an epigenetic marker of radiation resistance in medulloblastoma has a potential to open new…
“[…] our discovery of H3K27me3 as an epigenetic marker of radiation resistance in medulloblastoma has a potential to open new…
PRESS RELEASE: On May 12, 2023, a new editorial paper was published in Oncotarget, entitled, “Targeting H3K27me3 loss in…